NEW MJ NEWS

AbbVie to Present at the Bernstein 38th Annual Strategic Decisions Conference

AbbVie (NYSE: ABBV) will participate in the Bernstein 38th Annual Strategic Decisions Conference on Wednesday, June 1, 2022. Richard A. Gonzalez, chairman and chief executive officer, will present at 10:00 a.m. Central Time.

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-bernstein-38th-annual-strategic-decisions-conference-301554489.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Abattis Bioceuticals Corp. (ATTBF) Successful Completion of Acquisition of Gabriola Green Farms

Abattis Announces Successful Completion of Acquisition of Gabriola Green Farms Abattis Bioceuticals…

$MYEC Files Lawsuit Against Four Companies

MyECheck Files Lawsuit Against Four Companies, Seeks Recovery of 1.44 Billion Shares…

 Next Green Wave Holdings Inc. (NGW) (NXGWF) Receives City Council Approval To Move Forward With Second Facility

City Approval of Conditional Use Permits for Next Green Wave’s Extraction and…

Tilray Brands, Inc. (TLRY) Receives Approval for First Medical Cannabis Extract in Portugal

Tilray Medical Receives Approval for First Medical Cannabis Extract in Portugal Tilray…